The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Diabetes Management-Global Market Insights and Sales Trends 2024
Synopsis
Diabetes, scientifically known as diabetes mellitus, is a clinical condition where person has an elevated blood glucose level.
The global Diabetes Management market size is expected to reach US$ 13150 million by 2029, growing at a CAGR of 13.5% from 2023 to 2029. The market is mainly driven by the significant applications of Diabetes Management in various end use industries. The expanding demands from the Hospital, Clinic and Home Care,, are propelling Diabetes Management market. Monitoring Devices, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Diagnostic Devices segment is estimated at % CAGR for the next seven-year period.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Diabetes Management, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Diabetes Management market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Diabetes Management market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Diabetes Management sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Diabetes Management covered in this report include Ascensia Diabetes Care, Abbott Laboratories, Medtronic, Roche, Dexcom, Insulet Corporation, Tandem Diabetes Care, LifeScan and AgaMatrix, etc.
The global Diabetes Management market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Ascensia Diabetes Care
Abbott Laboratories
Medtronic
Roche
Dexcom
Insulet Corporation
Tandem Diabetes Care
LifeScan
AgaMatrix
Animas
ARKRAY
BD
Beta Bionics.
Eli Lilly
Global Diabetes Management market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Diabetes Management market, Segment by Type:
Monitoring Devices
Diagnostic Devices
Insulin Delivery Devices
Other Devices
Global Diabetes Management market, by Application
Hospital
Clinic
Home Care
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Diabetes Management companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Diabetes, scientifically known as diabetes mellitus, is a clinical condition where person has an elevated blood glucose level.
The global Diabetes Management market size is expected to reach US$ 13150 million by 2029, growing at a CAGR of 13.5% from 2023 to 2029. The market is mainly driven by the significant applications of Diabetes Management in various end use industries. The expanding demands from the Hospital, Clinic and Home Care,, are propelling Diabetes Management market. Monitoring Devices, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Diagnostic Devices segment is estimated at % CAGR for the next seven-year period.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Diabetes Management, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Diabetes Management market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Diabetes Management market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Diabetes Management sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Diabetes Management covered in this report include Ascensia Diabetes Care, Abbott Laboratories, Medtronic, Roche, Dexcom, Insulet Corporation, Tandem Diabetes Care, LifeScan and AgaMatrix, etc.
The global Diabetes Management market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Ascensia Diabetes Care
Abbott Laboratories
Medtronic
Roche
Dexcom
Insulet Corporation
Tandem Diabetes Care
LifeScan
AgaMatrix
Animas
ARKRAY
BD
Beta Bionics.
Eli Lilly
Global Diabetes Management market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Diabetes Management market, Segment by Type:
Monitoring Devices
Diagnostic Devices
Insulin Delivery Devices
Other Devices
Global Diabetes Management market, by Application
Hospital
Clinic
Home Care
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Diabetes Management companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Diabetes Management
1.1 Diabetes Management Market Overview
1.1.1 Diabetes Management Product Scope
1.1.2 Diabetes Management Market Status and Outlook
1.2 Global Diabetes Management Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Diabetes Management Market Size by Region (2018-2029)
1.4 Global Diabetes Management Historic Market Size by Region (2018-2023)
1.5 Global Diabetes Management Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Diabetes Management Market Size (2018-2029)
1.6.1 North America Diabetes Management Market Size (2018-2029)
1.6.2 Europe Diabetes Management Market Size (2018-2029)
1.6.3 Asia-Pacific Diabetes Management Market Size (2018-2029)
1.6.4 Latin America Diabetes Management Market Size (2018-2029)
1.6.5 Middle East & Africa Diabetes Management Market Size (2018-2029)
2 Diabetes Management Market by Type
2.1 Introduction
2.1.1 Monitoring Devices
2.1.2 Diagnostic Devices
2.1.3 Insulin Delivery Devices
2.1.4 Other Devices
2.2 Global Diabetes Management Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Diabetes Management Historic Market Size by Type (2018-2023)
2.2.2 Global Diabetes Management Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Diabetes Management Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Diabetes Management Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Diabetes Management Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Diabetes Management Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Diabetes Management Revenue Breakdown by Type (2018-2029)
3 Diabetes Management Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Home Care
3.2 Global Diabetes Management Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Diabetes Management Historic Market Size by Application (2018-2023)
3.2.2 Global Diabetes Management Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Diabetes Management Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Diabetes Management Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Diabetes Management Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Diabetes Management Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Diabetes Management Revenue Breakdown by Application (2018-2029)
4 Diabetes Management Competition Analysis by Players
4.1 Global Diabetes Management Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Diabetes Management as of 2022)
4.3 Date of Key Players Enter into Diabetes Management Market
4.4 Global Top Players Diabetes Management Headquarters and Area Served
4.5 Key Players Diabetes Management Product Solution and Service
4.6 Competitive Status
4.6.1 Diabetes Management Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Ascensia Diabetes Care
5.1.1 Ascensia Diabetes Care Profile
5.1.2 Ascensia Diabetes Care Main Business
5.1.3 Ascensia Diabetes Care Diabetes Management Products, Services and Solutions
5.1.4 Ascensia Diabetes Care Diabetes Management Revenue (US$ Million) & (2018-2023)
5.1.5 Ascensia Diabetes Care Recent Developments
5.2 Abbott Laboratories
5.2.1 Abbott Laboratories Profile
5.2.2 Abbott Laboratories Main Business
5.2.3 Abbott Laboratories Diabetes Management Products, Services and Solutions
5.2.4 Abbott Laboratories Diabetes Management Revenue (US$ Million) & (2018-2023)
5.2.5 Abbott Laboratories Recent Developments
5.3 Medtronic
5.3.1 Medtronic Profile
5.3.2 Medtronic Main Business
5.3.3 Medtronic Diabetes Management Products, Services and Solutions
5.3.4 Medtronic Diabetes Management Revenue (US$ Million) & (2018-2023)
5.3.5 Roche Recent Developments
5.4 Roche
5.4.1 Roche Profile
5.4.2 Roche Main Business
5.4.3 Roche Diabetes Management Products, Services and Solutions
5.4.4 Roche Diabetes Management Revenue (US$ Million) & (2018-2023)
5.4.5 Roche Recent Developments
5.5 Dexcom
5.5.1 Dexcom Profile
5.5.2 Dexcom Main Business
5.5.3 Dexcom Diabetes Management Products, Services and Solutions
5.5.4 Dexcom Diabetes Management Revenue (US$ Million) & (2018-2023)
5.5.5 Dexcom Recent Developments
5.6 Insulet Corporation
5.6.1 Insulet Corporation Profile
5.6.2 Insulet Corporation Main Business
5.6.3 Insulet Corporation Diabetes Management Products, Services and Solutions
5.6.4 Insulet Corporation Diabetes Management Revenue (US$ Million) & (2018-2023)
5.6.5 Insulet Corporation Recent Developments
5.7 Tandem Diabetes Care
5.7.1 Tandem Diabetes Care Profile
5.7.2 Tandem Diabetes Care Main Business
5.7.3 Tandem Diabetes Care Diabetes Management Products, Services and Solutions
5.7.4 Tandem Diabetes Care Diabetes Management Revenue (US$ Million) & (2018-2023)
5.7.5 Tandem Diabetes Care Recent Developments
5.8 LifeScan
5.8.1 LifeScan Profile
5.8.2 LifeScan Main Business
5.8.3 LifeScan Diabetes Management Products, Services and Solutions
5.8.4 LifeScan Diabetes Management Revenue (US$ Million) & (2018-2023)
5.8.5 LifeScan Recent Developments
5.9 AgaMatrix
5.9.1 AgaMatrix Profile
5.9.2 AgaMatrix Main Business
5.9.3 AgaMatrix Diabetes Management Products, Services and Solutions
5.9.4 AgaMatrix Diabetes Management Revenue (US$ Million) & (2018-2023)
5.9.5 AgaMatrix Recent Developments
5.10 Animas
5.10.1 Animas Profile
5.10.2 Animas Main Business
5.10.3 Animas Diabetes Management Products, Services and Solutions
5.10.4 Animas Diabetes Management Revenue (US$ Million) & (2018-2023)
5.10.5 Animas Recent Developments
5.11 ARKRAY
5.11.1 ARKRAY Profile
5.11.2 ARKRAY Main Business
5.11.3 ARKRAY Diabetes Management Products, Services and Solutions
5.11.4 ARKRAY Diabetes Management Revenue (US$ Million) & (2018-2023)
5.11.5 ARKRAY Recent Developments
5.12 BD
5.12.1 BD Profile
5.12.2 BD Main Business
5.12.3 BD Diabetes Management Products, Services and Solutions
5.12.4 BD Diabetes Management Revenue (US$ Million) & (2018-2023)
5.12.5 BD Recent Developments
5.13 Beta Bionics.
5.13.1 Beta Bionics. Profile
5.13.2 Beta Bionics. Main Business
5.13.3 Beta Bionics. Diabetes Management Products, Services and Solutions
5.13.4 Beta Bionics. Diabetes Management Revenue (US$ Million) & (2018-2023)
5.13.5 Beta Bionics. Recent Developments
5.14 Eli Lilly
5.14.1 Eli Lilly Profile
5.14.2 Eli Lilly Main Business
5.14.3 Eli Lilly Diabetes Management Products, Services and Solutions
5.14.4 Eli Lilly Diabetes Management Revenue (US$ Million) & (2018-2023)
5.14.5 Eli Lilly Recent Developments
6 North America
6.1 North America Diabetes Management Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Diabetes Management Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Diabetes Management Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Diabetes Management Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Diabetes Management Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Diabetes Management Market Dynamics
11.1 Diabetes Management Industry Trends
11.2 Diabetes Management Market Drivers
11.3 Diabetes Management Market Challenges
11.4 Diabetes Management Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
